We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This series brings together all documents relating to HMT statistical release: UK official holdings of international reserves.
Projects granted during 2014 that have a primary purpose of basic research into the endocrine system and metabolism.
Half a million women in England have accessed cheaper HRT - the main treatment for negative menopause symptoms - since last April.
Summary of two projects concerned with the mechanisms and potential impact of endocrine disruption effects in UK freshwater molluscs.
Anastrozole is now authorised as a preventative treatment for post-menopausal women at moderate or high risk of breast cancer.
Projects granted during 2016 that have a primary purpose of translational applied research - human endocrine and metabolism disorders.
An Expert Working Group (EWG) of the UK’s Commission on Human Medicines (CHM) has published their report on the use of hormone pregnancy tests (HPTs) and adverse effects relating to pregnancy including possible birth defects.
Projects granted during 2015 that have a primary purpose of translational and applied research: human endocrine and metabolism disorders.
Ability of the contraceptive progestin levonorgestrel to bind chemically with hydrosilane groups in addition-cure silicone elastomers
Minutes of the meeting and MHRA assessment report
This AGNIR report (RCE-1) considers the scientific evidence from studies relating to power frequency EMFs, melatonin and the risk of breast cancer.
Update of sexual and reproductive health profile indicators for reproductive health including abortions, birth outcomes and contraceptive use.
A year on from its Women’s Health Strategy, the government has announced a package of new measures to boost the health and wellbeing of women and girls.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).